Kenvue Inc. (NYSE:KVUE) Increases Dividend to $0.21 Per Share

Kenvue Inc. (NYSE:KVUE) announced a quarterly dividend on Wednesday, July 29th. Investors of record on Wednesday, August 12th will be given a dividend of 0.21 per share on Wednesday, August 26th. This represents a c) dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date is Wednesday, August 12th. This is a 1.2% increase from Kenvue’s previous quarterly dividend of $0.21.

Kenvue has a payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Equities research analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 67.5%.

Kenvue Price Performance

Shares of NYSE:KVUE traded up $0.03 during mid-day trading on Wednesday, reaching $19.77. The stock had a trading volume of 27,193,520 shares, compared to its average volume of 29,037,344. The business’s 50 day moving average price is $18.47 and its 200 day moving average price is $17.97. Kenvue has a 1 year low of $14.02 and a 1 year high of $22.35. The company has a market cap of $37.97 billion, a P/E ratio of 23.26, a price-to-earnings-growth ratio of 1.48 and a beta of 0.47. The company has a current ratio of 0.98, a quick ratio of 0.70 and a debt-to-equity ratio of 0.67.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.05. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $3.84 billion. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company’s revenue for the quarter was up 4.5% on a year-over-year basis. During the same period in the prior year, the firm earned $0.24 EPS. Research analysts expect that Kenvue will post 1.16 EPS for the current fiscal year.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.